BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

463 related articles for article (PubMed ID: 11001815)

  • 1. Maternal phenylketonuria: an international study.
    Koch R; Hanley W; Levy H; Matalon R; Rouse B; Trefz F; Guttler F; Azen C; Friedman E; Platt L; de la Cruz F
    Mol Genet Metab; 2000; 71(1-2):233-9. PubMed ID: 11001815
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Maternal phenylketonuria and hyperphenylalaninemia. An international survey of the outcome of untreated and treated pregnancies.
    Lenke RR; Levy HL
    N Engl J Med; 1980 Nov; 303(21):1202-8. PubMed ID: 7421947
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Maternal phenylketonuria: a metabolic teratogen.
    Levy HL; Ghavami M
    Teratology; 1996 Mar; 53(3):176-84. PubMed ID: 8761885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of nutrition in pregnancy with phenylketonuria and birth defects.
    Matalon KM; Acosta PB; Azen C
    Pediatrics; 2003 Dec; 112(6 Pt 2):1534-6. PubMed ID: 14654660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of high maternal blood phenylalanine on offspring congenital anomalies and developmental outcome at ages 4 and 6 years: the importance of strict dietary control preconception and throughout pregnancy.
    Rouse B; Azen C
    J Pediatr; 2004 Feb; 144(2):235-9. PubMed ID: 14760268
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Maternal phenylketonuria. Review with emphasis on pathogenesis.
    Levy HL
    Enzyme; 1987; 38(1-4):312-20. PubMed ID: 3326736
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of the phenylalanine hydroxylase gene on maternal phenylketonuria outcome.
    Güttler F; Azen C; Guldberg P; Romstad A; Hanley WB; Levy HL; Matalon R; Rouse BM; Trefz F; de la Cruz F; Koch R
    Pediatrics; 2003 Dec; 112(6 Pt 2):1530-3. PubMed ID: 14654659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pregnancy experiences in the woman with mild hyperphenylalaninemia.
    Levy HL; Waisbren SE; Güttler F; Hanley WB; Matalon R; Rouse B; Trefz FK; de la Cruz F; Azen CG; Koch R
    Pediatrics; 2003 Dec; 112(6 Pt 2):1548-52. PubMed ID: 14654663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Embryofetopathy of the newborn infant of a phenylketonuric mother. A diagnosis not to be missed].
    Farriaux JP; Dhondt JL; Largillière C; Lacombe A; Valat S; Puech F
    J Gynecol Obstet Biol Reprod (Paris); 1993; 22(1):49-52. PubMed ID: 8463567
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reproductive effects of maternal metabolic disorders: implications for pediatrics and obstetrics.
    Levy HL
    Turk J Pediatr; 1996; 38(3):335-44. PubMed ID: 8827903
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Women with phenylketonuria: successful management of pregnancy and implications.
    Bush RT; Dukes PC
    N Z Med J; 1985 Mar; 98(775):181-3. PubMed ID: 3856760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Maternal Phenylketonuria International Study: 1984-2002.
    Koch R; Hanley W; Levy H; Matalon K; Matalon R; Rouse B; Trefz F; Güttler F; Azen C; Platt L; Waisbren S; Widaman K; Ning J; Friedman EG; de la Cruz F
    Pediatrics; 2003 Dec; 112(6 Pt 2):1523-9. PubMed ID: 14654658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of untreated maternal phenylketonuria and hyperphenylalaninemia on the fetus.
    Levy HL; Waisbren SE
    N Engl J Med; 1983 Nov; 309(21):1269-74. PubMed ID: 6633585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Undiagnosed maternal phenylketonuria: own clinical experience and literature review.
    Bouchlariotou S; Tsikouras P; Maroulis G
    J Matern Fetal Neonatal Med; 2009 Oct; 22(10):943-8. PubMed ID: 19557660
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tyrosine supplementation during pregnancy in a woman with classical phenylketonuria. A case report.
    Lenke RR; Koch R; Fishler K; Platt LD
    J Reprod Med; 1983 Jun; 28(6):411-4. PubMed ID: 6887149
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pseudo-inherited form of left heart obstructive defects revealing maternal phenylketonuria].
    Saliba Z; Bah G; Martin D; Abadie V; Azar Z; Fraisse A; Sidi D; Kachaner J; Bonnet D
    Arch Mal Coeur Vaiss; 2000 May; 93(5):649-52. PubMed ID: 10858866
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Embryonic pathology caused by maternal phenylketonuria. A cause of underdiagnosed mental retardation. A report of 8 cases].
    Campistol Plana J; Arellano Pedrola M; Poo Argüelles P; Escofet Sotera C; Pérez Olarte P; Vilaseca Buscà MA
    An Esp Pediatr; 1999 Aug; 51(2):139-42. PubMed ID: 10495499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progeny, pregnancy and phenylketonuria.
    Bush RT; Dukes PC
    N Z Med J; 1975 Oct; 82(549):226-9. PubMed ID: 1059968
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiovascular defects among the progeny of mouse phenylketonuria females.
    McDonald JD; Dyer CA; Gailis L; Kirby ML
    Pediatr Res; 1997 Jul; 42(1):103-7. PubMed ID: 9212044
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Psychosocial characteristics of phenylketonuric women: birth defect prevention].
    Shiloh S; Amitay M; Aizin N; Normand M; Elitzur A; Hadar R; Cohen BE
    Harefuah; 1992 Apr; 122(8):487-92, 552. PubMed ID: 1398312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.